Trial Profile
A Placebo-Controlled Dose-Finding Study of JNS019 (Topiramate) in Migraine Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jul 2013
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 11 Mar 2010 New trial record